Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Beta-adrenergic receptors are differentially expressed in distinct interneuron subtypes in the rat hippocampus.

The Journal of comparative neurology | 2008

Noradrenaline (NA) acting via beta-adrenergic receptors (betaARs) plays an important role in the modulation of memory in the hippocampus. betaARs have been shown to be expressed in principal cells, but their distribution across different interneuron classes is unknown. We have used specific interneuron markers including calcium binding proteins (parvalbumin, calbindin, and calretinin) and neuropeptides (somatostatin, neuropeptide Y, and cholecystokinin) together with either beta1AR or beta2AR to determine the distribution of these receptors in all major subfields of the hippocampus. We found that beta1AR-expressing interneurons were more prevalent in the CA3 and CA1 regions of the hippocampus than in the dentate gyrus, where they were relatively sparse. beta2AR-expressing interneurons were more uniformly distributed between all three regions of the hippocampus. A high proportion of neuropeptide Y-containing interneurons in the dentate gyrus co-expressed beta2AR. beta1AR labeling was common in interneurons expressing somatostatin and parvalbumin in the CA3 and CA1 regions, particularly in the stratum oriens of these regions. beta2AR labeling was more likely to be found than beta1AR labeling in cholecystokinin-expressing interneurons. In contrast, calretinin-containing interneurons were virtually devoid of beta1AR or beta2AR labeling. These regional and interneuron type-specific differences suggest functionally distinct roles for NA in modulating hippocampal activity via activation of betaARs.

Pubmed ID: 18546278 RIS Download

Associated grants

  • Agency: Biotechnology and Biological Sciences Research Council, United Kingdom
    Id: BB/C502773/2
  • Agency: NIDDK NIH HHS, United States
    Id: DK41301

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Monoclonal anti Parvalbumin (antibody)

RRID:AB_10000343

This monoclonal targets parvalbumin

View all literature mentions

Monoclonal anti Calbindin D-28k (antibody)

RRID:AB_10000347

This monoclonal targets Calbindin D-28k

View all literature mentions

Cholecystokinin Antibody (antibody)

RRID:AB_10013360

This unknown targets Cholecystokinin

View all literature mentions

Anti-Neuropeptide Y (antibody)

RRID:AB_2236176

This polyclonal targets NPY

View all literature mentions

Somatostatin (D-20) (antibody)

RRID:AB_2302603

This polyclonal targets SST

View all literature mentions

beta2-AR (H-20) (antibody)

RRID:AB_630926

This polyclonal targets ADRB2

View all literature mentions